The Recombinant Bacillus subtilis Uncharacterized ABC Transporter Permease YtlD (YtlD) is a heterologously expressed protein derived from the Gram-positive bacterium Bacillus subtilis. As part of the ATP-binding cassette (ABC) transporter superfamily, YtlD is hypothesized to play roles in substrate transport across cellular membranes, though its precise biological function remains uncharacterized . The recombinant form of this protein enables biochemical and structural studies to elucidate its mechanisms and applications.
Sequence: A partial sequence (length not fully specified) expressed as a recombinant protein fused with an N-terminal His tag for purification .
| Parameter | Details |
|---|---|
| Species | Bacillus subtilis (strain 168) |
| Expression System | E. coli |
| Tag | His tag (position unspecified) |
| Form | Lyophilized powder |
| Storage | -20°C/-80°C (long-term); 4°C (short-term working aliquots) |
| Reconstitution | Deionized sterile water (0.1–1.0 mg/mL); 5–50% glycerol for stability |
Recombinant YtlD is synthesized using B. subtilis-optimized expression systems. Key steps include:
Gene Cloning: The ytlD gene is inserted into a plasmid under a strong promoter (e.g., P<sub>grac</sub>) .
Expression: Host cells (typically E. coli) are induced with IPTG or autoinduction systems for protein production .
Purification: Affinity chromatography (e.g., Ni-NTA resin) isolates the His-tagged protein .
Quality Control: SDS-PAGE and Western blotting confirm purity and identity .
While YtlD’s exact role is unconfirmed, ABC transporters in B. subtilis are implicated in:
Nutrient Uptake: Import of amino acids, ions, or metabolites .
Antibiotic Resistance: Export of toxins or cell wall-modifying molecules (e.g., YtrBCDEF) .
Cell Wall Homeostasis: Regulation of peptidoglycan synthesis and sporulation .
| Protein | Operon | Function | Key References |
|---|---|---|---|
| YtlD | Uncharacterized | Hypothesized substrate transport | |
| YtrBCDEF | ytrABCDEF | Cell wall thickening, antibiotic response | |
| YknZ | yknZ | Uncharacterized permease activity |
Functional Characterization: No direct studies on YtlD’s substrates or transport directionality (import/export) .
Structural Insights: No resolved 3D structure; computational models (e.g., AlphaFold) are unavailable for YtlD, unlike homologs such as Klebsiella YbtQ .
Regulatory Mechanisms: Unknown transcriptional or post-translational regulation .
Drug Discovery: Potential target for antimicrobials if linked to essential transport pathways .
Protein Engineering: Platform for studying ABC transporter mechanics due to B. subtilis’s GRAS status and secretion efficiency .
Industrial Enzymes: Secretion systems in B. subtilis could leverage YtlD for metabolite export .
KEGG: bsu:BSU30620
STRING: 224308.Bsubs1_010100016661
The ytlD gene is part of an operon structure typical of ABC transporters in B. subtilis. ABC transporter operons generally consist of genes encoding nucleotide-binding domains (NBDs) that bind and hydrolyze ATP, and transmembrane domains (TMDs) that form the substrate translocation pathway . In the case of ytlD, it encodes a permease protein that functions as part of the transmembrane domain component. The complete operon typically includes genes encoding the NBD protein, one or more permease proteins, and potentially a substrate-binding protein depending on whether it functions as an importer or exporter . When investigating ytlD, it's essential to examine the entire operon structure using genome browsers specific for B. subtilis to identify potential functional partners that may constitute the complete ABC transporter complex.
For recombinant production of ytlD protein, several B. subtilis-based expression systems can be employed with optimization strategies:
Plasmid-based expression systems: Autonomous plasmid vectors incorporating strong inducible promoters (e.g., Pspac, PxylA) offer high-yield expression of ytlD .
Integrated expression systems: Chromosomal integration methods provide stable expression without antibiotic selection pressure, ideal for long-term studies .
Secretion-based systems: For easier purification, expression can be coupled with secretion signals, though this may be challenging for membrane proteins like ytlD .
The following table outlines recommended expression systems for membrane proteins in B. subtilis:
| Expression System | Promoter | Induction Method | Advantages | Limitations |
|---|---|---|---|---|
| pHT vector series | P43 | Constitutive | Simple expression | No regulation |
| pHCMC series | PxylA | Xylose-inducible | Tight regulation | Medium copy number |
| pHT01 | Pgrac | IPTG-inducible | High expression | Possible leaky expression |
| Genome integration | Native ytlD promoter | Native regulation | Physiological levels | Lower yield |
When expressing ytlD, it's crucial to incorporate affinity tags (His6 or Strep-tag) for purification while considering their potential impact on protein folding and function .
Purifying ABC transporter permease proteins like ytlD presents several challenges due to their hydrophobic nature and membrane localization. Traditional detergent-based methods often lead to protein instability and functional loss. Recent methodologies have introduced detergent-free approaches, particularly using styrene-maleic acid (SMA) copolymers that extract membrane proteins within their native lipid environment .
The SMA extraction method offers significant advantages:
It maintains the protein within its native lipid bilayer environment
It preserves protein stability and function better than detergent extraction
It allows for purification of the protein-lipid complex (SMALP) via affinity chromatography
The purification protocol involves:
Expression of ytlD with appropriate affinity tags
Cell disruption and membrane fraction isolation
Membrane solubilization using SMA copolymer (typically 2.5%)
Affinity purification of the resulting SMALPs
This method has been successfully applied to various eukaryotic ABC transporters (ABCB1, ABCC1, ABCC4, ABCG2, and ABCC7) and shows promise for prokaryotic ABC transporters like ytlD .
Verification of ytlD expression in recombinant systems requires multiple complementary approaches:
Western blotting: Using antibodies against ytlD or attached affinity tags (His-tag, FLAG-tag) to detect the protein in membrane fractions. Expected molecular weight analysis should account for possible post-translational modifications .
Fluorescent fusion proteins: Creating ytlD-GFP fusion constructs to visualize membrane localization using fluorescence microscopy. This approach can confirm both expression and proper membrane targeting .
Mass spectrometry: Analyzing tryptic digests of membrane fractions to identify peptides specific to ytlD. This technique provides high specificity and can determine expression levels .
Functional assays: Measuring ATP hydrolysis activity in membrane preparations as a functional readout of ABC transporter expression. For ytlD specifically, establishing a correlation between expression and transport activity of potential substrates .
A typical expression verification workflow involves:
Initial screening via Western blot of whole-cell lysates
Subcellular fractionation to confirm membrane localization
Quantitative assessment through densitometry of Western blots compared to known standards
Functional validation through transport or ATPase assays
Determining substrate specificity of uncharacterized ABC transporters like ytlD requires a multi-faceted approach combining genomic, biochemical, and biophysical techniques:
Genomic context analysis: Examining genes adjacent to ytlD in the B. subtilis genome can provide clues about potential substrates. ABC transporters are often co-localized with genes involved in the metabolism of their substrates .
Comparative genomics: Identifying ytlD homologs in other organisms with known functions can suggest potential substrates. Phylogenetic analysis can place ytlD within known ABC transporter families .
Transport assays: Developing in vivo and in vitro transport assays using:
Radioactively labeled candidate substrates
Fluorescent substrate analogs
Growth phenotype analysis with potential toxic substrates
Binding studies: Substrate binding can be assessed through:
Isothermal titration calorimetry (ITC)
Surface plasmon resonance (SPR)
Fluorescence-based binding assays
Structural analysis: Cryo-EM or X-ray crystallography of ytlD in complex with potential substrates can definitively establish substrate specificity .
The most effective substrate identification workflow combines:
Initial bioinformatic prediction of substrate class
Medium-throughput screening of candidate substrates based on structural similarity
Validation through direct binding and transport assays
Confirmation via genetic approaches (deletion/complementation)
In the absence of crystallographic data, several computational and experimental approaches can effectively model ytlD structure-function relationships:
Homology modeling: Using solved structures of homologous ABC transporter permeases as templates. The quality depends on sequence similarity, which should be carefully assessed .
Ab initio modeling with experimental constraints: Combining computational prediction with experimental data from:
Cross-linking mass spectrometry (XL-MS) to identify spatial proximities
Hydrogen-deuterium exchange mass spectrometry (HDX-MS) to map solvent-accessible regions
Cysteine accessibility studies to probe transmembrane topology
Molecular dynamics simulations: Refining homology models through MD simulations in membrane environments to assess stability and conformational dynamics .
Evolutionary coupling analysis: Identifying co-evolving residues that likely interact in the three-dimensional structure, providing distance constraints for modeling.
Cryo-EM: While not atomic resolution, cryo-EM can provide medium-resolution structural information about membrane proteins like ytlD in native-like environments .
A comprehensive structural analysis workflow includes:
Generating initial models through homology modeling
Validating transmembrane topology through experimental approaches
Refining models using MD simulations and experimental constraints
Testing structure-based functional predictions through mutagenesis
This integrative approach has been successful for other ABC transporters and can reveal functional motifs and potential substrate-binding sites in ytlD.
Optimizing ytlD secretion in B. subtilis requires specialized approaches due to its nature as a membrane protein rather than a typical secreted protein. For study purposes, creating secretable versions involves:
Signal peptide optimization: The choice of signal peptide significantly impacts secretion efficiency. A systematic screening of B. subtilis signal peptides (SP) reveals varying efficiencies:
| Signal Peptide | Origin | Relative Secretion Efficiency |
|---|---|---|
| SPAmyE | α-amylase | High (100%) |
| SPAprE | Subtilisin | Medium-high (75-90%) |
| SPLipA | Lipase A | Medium (50-70%) |
| SPPhoD | Phosphodiesterase | Variable (30-80%) |
| SPYncM | Putative lipoprotein | High for specific proteins |
Domain engineering: For membrane proteins like ytlD, creating secretable versions requires:
Host strain optimization: Engineered B. subtilis strains with enhanced secretion capabilities:
Process optimization: Fermentation parameters significantly impact secretion:
A systematic optimization approach involves initial small-scale screening followed by statistical design of experiments (DoE) for multi-parameter optimization at bioreactor scale.
ABC transporters like ytlD may possess functions beyond simple transport. Distinguishing between transport and other activities requires:
Transport-specific assays: Direct measurement of substrate translocation using:
ATPase activity measurements: ABC transporters couple ATP hydrolysis to transport, allowing:
Separation of function mutations: Targeted mutations in:
Protein-protein interaction studies: Identifying interaction partners through:
Bacterial two-hybrid assays
Co-immunoprecipitation
Cross-linking followed by mass spectrometry
The correlation between ATP hydrolysis and transport can be assessed through the following parameters:
| Parameter | Definition | Typical Values | Significance |
|---|---|---|---|
| Basal ATPase | ATP hydrolysis without substrate | 5-20 nmol/min/mg | Background activity |
| Vmax | Maximum ATPase rate | 50-200 nmol/min/mg | Catalytic capacity |
| Km (ATP) | ATP concentration at half Vmax | 0.1-0.5 mM | ATP binding affinity |
| Transport coupling ratio | ATP molecules/substrate transported | 1-2 ATP/molecule | Energetic efficiency |
| Substrate stimulation | Fold increase in ATPase with substrate | 1.5-5 fold | Transport coupling |
Uncoupling of ATP hydrolysis from transport may indicate regulatory or structural roles beyond simple substrate translocation.
Investigating ytlD interactions with other ABC transporter components requires specialized techniques for membrane protein complexes:
Co-purification approaches:
In vivo interaction studies:
Cross-linking mass spectrometry (XL-MS):
Functional complementation:
Construction of chimeric proteins with components from characterized ABC transporters
Genetic complementation of known ABC transporter mutants
Analysis of dominant negative mutations
The typical ABC transporter complex formation involves specific components with defined roles:
| Component | Function | Detection Method | Typical Stoichiometry |
|---|---|---|---|
| NBD | ATP binding/hydrolysis | ATPase activity | 2 (homodimer or heterodimer) |
| Permease (ytlD) | Substrate translocation | Transport assays | 2 (homodimer or heterodimer) |
| Substrate-binding protein | Substrate capture (importers) | Binding assays | 1-2 |
| Accessory proteins | Regulation/stability | Co-IP, proteomics | Variable |
A comprehensive interaction study should map both the physical contacts and functional cooperation between ytlD and its partner proteins in the ABC transporter complex.
Site-directed mutagenesis of ytlD requires specialized approaches for B. subtilis genes, with several effective methodologies:
PCR-based site-directed mutagenesis:
QuikChange method adapted for B. subtilis plasmids
Gibson Assembly with mutagenic primers
Overlap extension PCR incorporating desired mutations
CRISPR-Cas9 genome editing in B. subtilis:
Alanine-scanning mutagenesis:
Systematic replacement of residues with alanine
Particularly valuable for identifying functional residues in transmembrane segments
Can be performed in blocks or individual residues
Conservation-guided mutagenesis:
For functional analysis of mutations, a systematic approach includes:
| Mutation Type | Target Residues | Expected Outcome | Analysis Method |
|---|---|---|---|
| Functional motifs | Walker A/B, signature motif | Impaired ATP hydrolysis | ATPase assays |
| TM helices | Charged/polar residues | Altered substrate specificity | Transport assays |
| Cytoplasmic loops | Interface residues | Disrupted NBD-TMD communication | Conformational studies |
| Conservative substitutions | Similar amino acids | Subtle functional changes | Detailed kinetic analysis |
| Radical substitutions | Different properties | Significant functional changes | Complementation tests |
The most informative mutations are those that separate different functions (e.g., ATP binding vs. hydrolysis, substrate binding vs. translocation), allowing delineation of the mechanism.
While B. subtilis is the native host for ytlD, alternative expression systems may offer advantages for specific experimental purposes:
E. coli-based systems:
Cell-free expression systems:
Yeast expression systems:
Mammalian cell expression:
HEK293 cells for transient expression
CHO cells for stable cell lines
Advantages include complex eukaryotic membrane environment
Limitations include lower yields and higher costs
Comparative expression analysis across systems:
| Expression System | Typical Yield | Expression Time | Membrane Environment | Cost | Technical Difficulty |
|---|---|---|---|---|---|
| B. subtilis | 0.5-5 mg/L | 24-48 hrs | Native (Gram+) | Low | Medium |
| E. coli | 1-10 mg/L | 16-24 hrs | Gram- | Very low | Low |
| Cell-free | 0.1-1 mg/mL | 4-24 hrs | Defined lipids | High | Medium |
| P. pastoris | 2-10 mg/L | 48-96 hrs | Eukaryotic | Medium | High |
| Mammalian cells | 0.1-2 mg/L | 48-72 hrs | Complex eukaryotic | Very high | Very high |
The optimal choice depends on the specific experimental goals, with E. coli offering simplicity and high yields, while cell-free systems provide greater control over the membrane environment.
Contradictory data regarding ABC transporter permease proteins like ytlD are common due to experimental variables and complex biology. Resolving these contradictions requires systematic approaches:
Standardization of experimental conditions:
Multi-method verification:
Combining different localization techniques:
a) Fluorescent protein fusions
b) Immunofluorescence microscopy
c) Biochemical fractionation
d) Protease accessibility assays
Cross-validating functional data using independent methods:
a) Transport assays with different detection methods
b) ATPase activity measurements
c) Binding studies with varied techniques
Context-dependent analysis:
Statistical and data analysis approaches:
Meta-analysis of multiple experiments
Bayesian approaches to integrate conflicting data sets
Principal component analysis to identify key variables affecting outcomes
Framework for resolving contradictory data:
| Contradiction Type | Example | Resolution Approach | Validation Method |
|---|---|---|---|
| Localization | Membrane vs. cytoplasmic | Temporal analysis of localization | Time-course imaging |
| Substrate specificity | Different substrates reported | Competitive transport assays | Direct binding studies |
| Function | Transport vs. regulatory role | Separation-of-function mutations | Genetic epistasis analysis |
| Structure | Different predicted topologies | Cysteine accessibility mapping | Cross-linking studies |
| Expression level | Variable detection in proteomics | Quantitative Western blotting | Targeted mass spectrometry |
This systematic approach acknowledges that contradictions often reveal biological complexity rather than experimental error, potentially uncovering conditional functionality or regulatory mechanisms.
ABC transporters often contribute to antimicrobial resistance, making ytlD a potential factor in B. subtilis resistance mechanisms. Effective study methods include:
Genetic approaches:
Biochemical approaches:
Physiological and systems approaches:
Structural approaches:
Modeling of antimicrobial binding sites
Identification of resistance mutations in ytlD
Structure-guided design of inhibitors
Antimicrobial resistance profiling protocol:
| Stage | Method | Outcome Measure | Significance |
|---|---|---|---|
| Initial screening | Disk diffusion assays | Zone of inhibition | Qualitative resistance |
| Quantitative assessment | Broth microdilution | MIC values | Quantitative resistance |
| Mechanism study | Efflux inhibitor studies | MIC reduction | Confirmation of efflux |
| Direct transport | Fluorescent substrate accumulation | Intracellular concentration | Direct evidence |
| Expression analysis | qRT-PCR/Western blot | Expression level | Regulation data |
| Resistance selection | Serial passage | Resistance mutations | Evolution of resistance |
The relationship between ABC transporter activity and antimicrobial resistance is complex, often involving substrate specificity changes that can be detected through carefully designed comparative studies across multiple antimicrobial classes.
Predicting ytlD function and evolutionary relationships requires specialized bioinformatic approaches for ABC transporters:
Sequence analysis tools:
Structure prediction tools:
Genomic context analysis:
STRING: Protein-protein interaction networks and genomic neighborhood
IMG/MicrobesOnline: Comparative genomics and operon structure analysis
SubtiWiki: B. subtilis-specific genome browser and annotation
Specialized ABC transporter resources:
ABCMdb: ABC Membrane Protein Database
TransportDB: Transport protein analysis
Membrane Protein Data Bank: Structural information
Workflow for comprehensive computational analysis:
| Analysis Step | Tools | Output | Interpretation |
|---|---|---|---|
| Initial characterization | TCDB, Pfam | ABC transporter classification | Family/subfamily assignment |
| Homology detection | PSI-BLAST, HMMer | Homologs across species | Evolutionary conservation |
| Genomic context | STRING, SubtiWiki | Operonic structure, functional partners | Functional associations |
| Structure prediction | AlphaFold2, SWISS-MODEL | 3D structural model | Substrate binding sites, membrane topology |
| Evolutionary analysis | MEGA, MrBayes | Phylogenetic tree | Evolutionary history |
| Substrate prediction | TransportTP, machine learning | Potential substrates | Functional hypothesis |
The most valuable prediction combines multiple lines of evidence, with greater confidence assigned to predictions supported by different computational approaches. For uncharacterized proteins like ytlD, computational predictions should guide experimental design rather than replace empirical testing.
Solubilization and purification of ytlD requires specialized approaches for membrane proteins:
Membrane preparation:
Solubilization methods comparison:
| Solubilization Method | Advantages | Limitations | Typical Yield | Structural Integrity |
|---|---|---|---|---|
| Detergent (DDM) | Well-established | Potential denaturation | Moderate (40-60%) | Variable |
| Detergent (LMNG) | Enhanced stability | High cost | Good (50-70%) | Good |
| SMA copolymer | Native lipid environment | Limited compatibility | Moderate (30-50%) | Excellent |
| Amphipols | Stabilization without detergent | Requires initial detergent | Moderate (40-60%) | Very good |
| Nanodiscs (MSP) | Defined bilayer environment | Complex preparation | Low (20-40%) | Excellent |
Purification strategy:
Stability optimization:
The optimal purification protocol involves:
Initial solubilization screening to identify conditions that maintain ATPase activity
Small-scale purification trials with activity measurements
Scaled-up purification with stability assessment
Quality control through homogeneity analysis (SEC-MALS, negative stain EM)
Styrene-maleic acid (SMA) copolymer extraction has emerged as particularly promising for ABC transporters, maintaining them in native lipid environments without conventional detergents .
Determining whether ytlD functions in an import or export capacity requires systematic experimental design:
Genetic architecture analysis:
Transport directionality assays:
Biochemical approaches:
Reconstitution studies:
Experimental decision tree:
| Experiment | Result for Importer | Result for Exporter | Controls |
|---|---|---|---|
| Gene cluster analysis | SBP genes present | No SBP genes | Known importers/exporters |
| Substrate uptake assay | Enhanced in overexpression | Reduced in overexpression | Transport-deficient mutant |
| Drug resistance | Sensitization when overexpressed | Resistance when overexpressed | Known MDR transporters |
| ATP stimulation pattern | ATP binding initiates transport cycle | Substrate binding initiates ATP cycles | Walker A/B mutants |
| Reconstituted system | Inward transport requiring SBPs | Outward transport without SBPs | Defined orientation controls |
The collected evidence across multiple experimental approaches provides strong classification of ytlD as either an importer or exporter component, guiding further functional characterization.
High-throughput screening for ytlD substrates and inhibitors can utilize several complementary approaches:
Growth-based screening platforms:
Biochemical high-throughput assays:
ATPase activity modulation screening:
a) Colorimetric phosphate release assays (malachite green)
b) Coupled enzyme assays (pyruvate kinase/lactate dehydrogenase)
c) Luminescent ADP detection assays
Transport assays using fluorescent substrates:
a) Membrane vesicle-based accumulation
b) Whole-cell fluorescence monitoring
c) FRET-based substrate interaction assays
Biophysical screening methods:
Thermal shift assays (differential scanning fluorimetry)
Surface plasmon resonance binding screens
Fragment-based screening using NMR
In silico approaches:
Virtual screening against modeled substrate-binding sites
Pharmacophore-based screening
Machine learning prediction of substrates based on known transporters
Workflow optimization for different screening objectives:
| Screening Objective | Primary Screen | Secondary Validation | Throughput | Success Rate |
|---|---|---|---|---|
| Natural substrate identification | Biolog PM plates | Transport assays | Medium (100s) | 5-15% |
| Inhibitor discovery | ATPase modulation | Growth inhibition | High (1000s) | 0.1-1% |
| Substrate specificity profiling | Structural analogs | Competitive inhibition | Medium (100s) | 10-30% |
| Allosteric modulators | Thermal shift | Conformational analysis | High (1000s) | 0.5-2% |
For ytlD specifically, combining computational prediction with focused libraries of compounds related to predicted substrate classes significantly increases the likelihood of identifying physiologically relevant interactions compared to random compound screening.
ABC transporters often play crucial roles in stress responses. Effective approaches for investigating ytlD's role include:
Transcriptional regulation analysis:
Phenotypic characterization:
Stress survival assays comparing wild-type and ytlD mutants:
a) Oxidative stress (H₂O₂, paraquat)
b) Osmotic stress (salt, sugar)
c) pH stress (acid, alkaline)
d) Temperature stress (heat shock, cold shock)
e) Antimicrobial compounds
Growth curve analysis under stress conditions
Omics approaches:
Interaction studies:
Stress-dependent protein-protein interactions
Co-regulation with known stress response systems
Genetic interaction screens under stress conditions
Stress response characterization protocol:
| Stress Type | Assay Method | Parameters Measured | Expected Phenotype If Involved |
|---|---|---|---|
| Oxidative | H₂O₂ challenge | Survival rate | Decreased survival in Δytld |
| Osmotic | NaCl gradient plates | Growth zone | Growth inhibition at lower concentrations |
| Membrane integrity | Membrane permeabilization assays | Dye uptake | Increased permeability in Δytld |
| Nutrient limitation | Minimal media growth | Lag phase, growth rate | Extended lag or reduced growth rate |
| Combined stresses | Checkerboard assays | Growth inhibition | Synergistic effects with other stressors |
The involvement of ytlD in stress responses would be confirmed by both altered expression patterns under stress and phenotypic consequences of gene deletion or overexpression, particularly if complementation with the wild-type gene restores normal stress resistance.
Expression controls:
Empty vector controls to account for vector effects
Inactive mutant controls (e.g., Walker A/B mutations in ATP-binding domain)
Expression level normalization across different constructs
Appropriate tags/fusions on both N- and C-termini to verify full-length expression
Western blotting to confirm correct protein size and absence of degradation
Functional controls:
Localization controls:
System-specific controls:
Proper folding verification (native vs. SDS-PAGE mobility)
Oligomeric state analysis (native PAGE, crosslinking)
Lipid composition controls in reconstituted systems
pH and ionic strength controls for activity measurements
Essential control framework for comprehensive characterization:
| Experiment Type | Critical Controls | Purpose | Implementation |
|---|---|---|---|
| Expression analysis | Empty vector, housekeeping gene | Account for vector effects, normalize expression | Parallel transformation and analysis |
| Transport assays | No ATP, non-hydrolyzable ATP analog | Verify ATP dependence | Side-by-side assays with ATP variants |
| Substrate specificity | Structurally related non-substrates | Confirm selectivity | Competitive inhibition studies |
| Localization | Membrane marker, cytoplasmic marker | Verify correct targeting | Co-localization studies |
| Interaction studies | Unrelated membrane protein | Control for non-specific interactions | Parallel pulldown experiments |
| Complementation | Inactive mutant version | Verify function-specific complementation | Parallel transformation of mutants |